Monoctanoin
drug drugOn this page
Also known as Capmul 8210MoctaninMonooctanoinSID8139903SID144205891SID170465212SID144211852
Summary
Monoctanoin (CHEMBL6066833) is an approved unknown.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Unknown
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL6066833 |
| Name | Monoctanoin |
| Type | Unknown |
| Max phase | 4 |
Also known as: Capmul 8210, Moctanin, Monoctanoin, Monooctanoin, SID8139903, MONOCTANOIN, SID144205891, SID170465212, SID144211852, monoctanoin
Targets
Targets
Broader ChEMBL bioactivity targets: 2 (assay-derived). Sample: Ferritin light chain, Beta-lactamase.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.